Loading Otnox...
Otnox
UKUnited Kingdom·Buyer: Leeds Teaching Hospitals NHS Trust

Ono type DX Breast Recurrence Score Test

Awarded·26 Oct 2026·GBP 405,000

Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.

Deadline

30.06.2026

Published

26.10.2026

Awarded

26.10.2026

Otnox

Find tenders worth bidding for.

Create an account to explore this tender and find similar opportunities.

  • Tender documentsReview available files in one workspace.
  • Requirements and risksRequest a document analysis with references to the sources.
  • Your tender selectionContinue with your selected markets and sectors.